GeneNews Limited

(T.GEN)

By |

Profile

GeneNews Ltd is focused on developing and commercializing proprietary molecular diagnostic tests for early detection of diseases and personalized health management, with a primary focus on cancer-related indications.

Contact Information

Website: www.genenews.com
Email: contact@genenews.com
Main Phone: +1 905 209-2030
Address: 445 Apple Creek Boulevard
Address 2: Suite 220
State: ON
City / Town: Markham
Country: CAN
Postal Code: L3R 9X7

Issuer Information

Exchange: TSX
CEO: James R. Howard-Tripp
Employees: 18
NAICS: In-Vitro Diagnostic Substance Manufacturing (325413)
$ 0.055 $ 0. (0.00%)
Last Price 0.055 Change $ 0. Change % 0.00 Tick N/A
Bid 0.055 Bid Size 404,000.00 Ask 0.06 Ask Size 446,000.00
Open 0.06 High 0.06 Low 0.055 Prev Close 0.055
Last Trade Volume 45,000 52 Wk Hi 0.24 52 Wk Low 0.05
Market Cap 7.9 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 143,588,177.00 EPS (TTM) -0.03 PE Ratio N/A Exchange TSX
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 3 3 3 3
Low Target Price Estimate 3 3 3 3
Mean Target Price Estimate 3 3 3 3
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 06/05/14 06/05/14 06/05/14 06/05/14
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 1